TOG Review (RCOG Journal)

MRCOG Part 2

Gynaecological Problems

Investigation and management of postcoital bleeding

Key Statistics

  • 0.7–9.0% — Community prevalence of PCB
  • 1:2400 — Cervical cancer risk, PCB age 45–54
  • 50% — PCB with no identifiable cause

Don't-miss facts

  1. PCB PPV for cervical cancer is low: 1:44,000 (age 20–24) vs 1:2400 (age 45–54) – but excluding cervical cancer is still the principal aim

  2. Suspicious cervix on exam → refer directly to colposcopy within 2 weeks; do NOT take a screening smear in a suspicious cervix

  3. Ask HARK questions (Humiliation, Afraid, Rape, Kick) – all PCB patients screened for domestic/sexual abuse

  4. Chlamydia: azithromycin 1 g stat + 500 mg OD ×2 days or doxycycline 100 mg BD ×7 days. Gonorrhoea: ceftriaxone 1 g IM stat + mandatory test of cure

  5. Cervical polyps: symptomatic/atypical cytology → avulse + histology (silver nitrate haemostasis); postmenopausal women – up to 55% also have endometrial pathology – add hysteroscopy/sampling

  6. CIN1 → re-screen at 12 months; CIN2/3 → see-and-treat excision (2× relative ↑ preterm birth risk, absolute risk low)

  7. Lichen sclerosus – 4.0–6.7% vulval SCC risk – annual review

  8. A previous negative screening test does NOT exclude cervical cancer – never let it delay colposcopy referral if clinically suspicious

Key drug regimens at a glance

Chlamydia: azithromycin 1g stat+500mg OD×2d / doxycycline 100mg BD×7d Gonorrhoea: ceftriaxone 1g IM stat + test of cure

PID outpatient: IM ceftriaxone 1g + doxycycline 100mg BD + metronidazole 400mg BD ×14d

Abbreviation Key

  • PCB — postcoital bleeding
  • PID — pelvic inflammatory disease
  • IMB — intermenstrual bleeding
  • BASHH — British Association for Sexual Health and HIV
  • CIN — cervical intraepithelial neoplasia
  • GUM — genitourinary medicine
  • VIN — vulval intraepithelial neoplasia
  • USS — ultrasound scan
  • VAIN — vaginal intraepithelial neoplasia
  • IUCD — intrauterine contraceptive device
  • hrHPV — high-risk human papillomavirus
  • DHEA — dehydroepiandrosterone
  • NAAT — nucleic acid amplification test
  • FGM — female genital mutilation
  • STI — sexually transmitted infection
  • HRT — hormone replacement therapy

Source: Owens GL et al. Investigation and management of postcoital bleeding. The Obstetrician & Gynaecologist 2022;24:24–30. doi:10.1111/tog.12780

MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).

Included with a Pass Package

  • Audio overview of this guideline
  • Practice questions drawn from it
  • AI tutor answers grounded in its text
  • Your own annotations
Start free